Prevalence of BRCA1 expression in epithelial ovarian cancer: Immunohistochemical study

Journal of the Medical Association of Thailand

Volumn 90, Issue 1, 2007, Pages 9-14

  Sirisabya, Nakarin ^a   Manchana, Tarinee ^a   Termrungreunglert, Wichai ^a   Triratanachat, Surang ^a   Charuruks, Navapun ^a   Tresukosol, Damrong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

BRCA1; Immunohistochemistry; Ovarian cancer

Indexed keywords

BRCA1 PROTEIN; FORMALDEHYDE; PARAFFIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GYNECOLOGY; HOSPITAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOLOGY; OVARY CANCER; OVERALL SURVIVAL; PREVALENCE; PROTEIN EXPRESSION; SURVIVAL TIME;

DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENES, BRCA1; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OVARIAN NEOPLASMS; PARAFFIN EMBEDDING; SURVIVAL ANALYSIS;

EID: 33847005066     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
2. Stratton JF, Gayther SA, Russell P, Dearden J, Gore M, Blake P, et al. Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 1997; 336: 1125-30.
3. Jacobs IJ, Smith SA, Wiseman RW, Futreal PA, Harrington T, Osborne RJ, et al. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus. Cancer Res 1993; 53: 1218-21.
4. Schildkraut JM, Collins NK, Dent GA, Tucker JA, Barrett JC, Berchuck A, et al. Loss of heterozygosity on chromosome 17q11-21 in cancers of women who have both breast and ovarian cancer. Am J Obstet Gynecol 1995; 172: 908-13.
5. Takahashi H, Behbakht K, McGovern PE, Chiu HC, Couch FJ, Weber BL, et al. Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res 1995; 55: 2998-3002.
6. Berchuck A, Heron KA, Carney ME, Lancaster JM, Fraser EG, Vinson VL, et al. Frequency of germline and somatic BRCA1 mutations in ovarian cancer. Clin Cancer Res 1998; 4: 2433-7.
7. Cannistra SA. BRCA1 mutations and survival in women with ovarian cancer. N Engl J Med 1997; 336: 1254; author reply 1256-7.
8. Whitmore SE. BRCA1 mutations and survival in women with ovarian cancer. N Engl J Med 1997; 336: 1254-5; author reply 1256-7.
9. Modan B. BRCA1 mutations and survival in women with ovarian cancer. N Engl J Med 1997; 336: 1255; author reply 1256-7.
10. Johannsson OT, Ranstam J, Borg A, Olsson H. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. J Clin Oncol 1998; 16: 397-404.
11. Rubin SC, Benjamin I, Behbakht K, Takahashi H, Morgan MA, LiVolsi VA, et al. Clinical and pathological features of ovarian cancer in women with germline mutations of BRCA1. N Engl J Med 1996; 335: 1413-6.
12. Byrne TJ, Reece MT, Adams LA, Lane MA, Cohn GM. An antibody assay predictive of BRCA1 mutations in ovarian tumors and normal tissue. Oncol Rep 2000; 7: 949-53.
13. FIGO Cancer Committee. Staging announcement. Gynecol Oncol 1986; 25: 383-5.
14. Yang Q, Sakurai T, Mori I, Yoshimura G, Nakamura M, Nakamura Y, et al. Prognostic significance of BRCA1 expression in Japanese sporadic breast carcinomas. Cancer 2001; 92: 54-60.
15. Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE, et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 1994; 8: 399-404.
16. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994; 266: 120-2.
17. Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y. Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res 1991; 51: 5794-9.
18. Ben David Y, Chetrit A, Hirsh-Yechezkel G, Friedman E, Beck BD, Beller U, et al. Effect of BRCA mutations on the length of survival in epithelial ovarian tumors. J Clin Oncol 2002; 20: 463-6.
19. Boyd J, Sonoda Y, Federici MG, Bogomolniy F, Rhei E, Maresco DL, et al. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA 2000; 283: 2260-5.
20. Pierce LJ, Strawderman M, Narod SA, Oliviotto I, Eisen A, Dawson L, et al. Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol 2000; 18: 3360-9.
21. Sharan SK, Morimatsu M, Albrecht U, Lim DS, Regel E, Dinh C, et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking BRCA2. Nature 1997; 386: 804-10.
22. Thangaraju M, Kaufmann SH, Couch FJ. BRCA1 facilitates stress-induced apoptosis in breast and ovarian cancer cell lines. J Biol Chem 2000; 275: 33487-96.